Literature DB >> 2296642

Predicting gallstone composition with CT: in vivo and in vitro analysis.

K Brakel1, J S Laméris, H G Nijs, O T Terpstra, G Steen, B C Blijenberg.   

Abstract

Chemical composition of gallstones is of major importance in selecting patients for nonsurgical therapy. In a combined in vivo and in vitro study of predictive potential, 50 patients undergoing cholecystectomy were evaluated with computed tomography (CT) and either plain abdominal radiography or oral cholecystography (OCG). The largest stone surgically removed from each patient was subjected to in vitro CT and chemical analysis. The authors found an inverse relationship between CT attenuation numbers and cholesterol content and a good positive correlation between CT attenuation numbers and calcium content. In vivo CT analysis improved sensitivity, specificity, accuracy, and positive and negative predictive values compared to plain abdominal radiography and OCG in detection of cholesterol stones. Using their prediction rule (a CT number smaller than 140 HU indicates a pure cholesterol gallstone), the authors correctly classified gallstones in 17 (84%) of another 20 patients. In vivo CT analysis can enable reliable prediction of gallstone composition and should play an important role in the selection of patients for nonsurgical treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296642     DOI: 10.1148/radiology.174.2.2296642

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  The operative risk factors of cholelithiasis in the elderly.

Authors:  N Shinagawa; K Mashita; J Yura
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

2.  Is endoscopic ultrasound needed as an add-on test for gallstone diseases without choledocholithiasis on multidetector computed tomography?

Authors:  Byoung Wook Bang; Ji Taek Hong; Young Chul Choi; Seok Jeong; Don Haeng Lee; Hyung Kil Kim; Shin Goo Park; Yong Sun Jeon
Journal:  Dig Dis Sci       Date:  2012-06-23       Impact factor: 3.199

3.  Role of oral cholecystography, real-time ultrasound, and CT in evaluation of gallstones and gallbladder function.

Authors:  L Marzio; P Innocenti; N Genovesi; F Di Felice; A M Napolitano; R Contantini; E Di Giandomenico
Journal:  Gastrointest Radiol       Date:  1992

4.  Common bile duct stones on multidetector computed tomography: attenuation patterns and detectability.

Authors:  Chang Whan Kim; Jae Hyuck Chang; Yeon Soo Lim; Tae Ho Kim; In Seok Lee; Sok Won Han
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

5.  In vivo analysis of gallstone composition by computed tomography.

Authors:  J G Bova; W H Schwesinger; W E Kurtin
Journal:  Gastrointest Radiol       Date:  1992

6.  Prospective, multicenter study on value of computerized tomography (CT) in gallstone disease in predicting response to bile acid therapy.

Authors:  M L Petroni; R P Jazrawi; A Grundy; A Lanzini; M G Pigozzi; A Biasio; K W Heaton; J Virjee; T C Northfield
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

7.  Transhepatic topical dissolution of gallbladder stones with MTBE and EDTA. Results, side effects, and correlation with CT imaging.

Authors:  P Janowitz; K A Schumacher; W Swobodnik; W Kratzer; J Tudyka; J G Wechsler
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

8.  Composition of gall bladder stones associated with octreotide: response to oral ursodeoxycholic acid.

Authors:  S H Hussaini; S P Pereira; G M Murphy; C Kennedy; J A Wass; G M Besser; R H Dowling
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

9.  Symptomatic versus silent gallstones. Radiographic features and eligibility for nonsurgical treatment.

Authors:  E Ros; R Valderrama; C Bru; L Bianchi; J Terés
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

10.  In vitro comparison of different gall stone dissolution solvents.

Authors:  H Vergunst; O T Terpstra; H G Nijs; G Steen
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.